OptimizeRx Corporation

NASDAQ: OPRX · Real-Time Price · USD
16.98
-0.61 (-3.47%)
At close: Aug 15, 2025, 9:56 AM

OptimizeRx Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.38M 13.85M 18.21M 84.68M
Short-Term Investments
n/a n/a 55.93M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
296K 568.05K 5.05K 12.86K
Receivables
38.21M 37.29M 22.16M 24.8M
Inventory
n/a n/a n/a n/a
Other Current Assets
387K 404.47K n/a n/a
Total Current Assets
53.97M 54.33M 98.58M 115.11M
Property-Plant & Equipment
516K 722.3K 372.77K 472.64K
Goodwill & Intangibles
116.39M 127.75M 35.7M 25.39M
Total Long-Term Assets
117.2M 129.04M 36.07M 25.87M
Total Assets
171.17M 183.37M 134.65M 140.99M
Account Payables
2.16M 2.23M 1.55M 606.81K
Deferred Revenue
473K 171.84K 164.31K 1.39M
Short-Term Debt
2M 2M 89.9K 90.98K
Other Current Liabilities
n/a 5.55M 3.9M 4.29M
Total Current Liabilities
18.65M 17.88M 8.4M 9.37M
Long-Term Debt
30.82M 34.23M n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
35.52M 38.94M 144.53K 236.73K
Total Liabilities
54.17M 56.82M 8.54M 9.61M
Total Debt
33.19M 36.82M 234.43K 327.71K
Common Stock
20K 19.9K 18.29K 17.86K
Retained Earnings
-84.37M -64.26M -46.69M -35.25M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
117M 126.55M 126.11M 131.38M
Total Investments
n/a n/a 55.93M n/a